A statement of changes in beneficial ownership was filed with the SEC on August 11, 2026, disclosing that Mark J. Tarr, President and Chief Executive Officer of Encompass Health Corp (NYSE:EHC), sold a combined 173,148 shares of common stock on August 10, 2026.

Key Highlights

  • Reporting person: Mark J. Tarr, President and CEO of Encompass Health Corp, filed as an individual reporting person.
  • First sale transaction: 171,569 shares disposed of at a weighted average price of $125.46, with individual transaction prices ranging from $124.93 to $125.92.
  • Second sale transaction: 1,579 shares disposed of at a weighted average price of $126.06, with individual transaction prices ranging from $125.93 to $126.22.
  • Remaining ownership: Following both transactions, Tarr directly beneficially owned 267,814 shares of Encompass Health common stock.
  • Transaction date: Both disposals occurred on August 10, 2026, with the filing signed on August 11, 2026 by Patrick Darby as attorney-in-fact for Mark J. Tarr.

Details of Tarr's Share Disposals at Encompass Health

According to the filing, Mark J. Tarr holds dual roles at Encompass Health Corp as both a Director and the company's President and Chief Executive Officer. Encompass Health, traded on the New York Stock Exchange under the ticker EHC, is a provider of inpatient rehabilitation services operating across the United States, with its principal address listed in the filing as 9001 Liberty Parkway, Birmingham, Alabama 35242.

The filing reports two separate disposal transactions on August 10, 2026, both coded "S," indicating open-market sales. In the first transaction, 171,569 shares were sold at a weighted average price of $125.46 per share, across multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The second transaction involved 1,579 shares sold at a weighted average price of $126.06 per share, across multiple transactions at prices ranging from $125.93 to $126.22, inclusive. Both prices are described in the filing as weighted averages.

The filing notes that Tarr "undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range." After the two transactions, the filing reports Tarr's direct beneficial ownership stood at 267,814 shares of Encompass Health common stock. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing discloses two open-market sales of Encompass Health common stock by President and CEO Mark J. Tarr on August 10, 2026, totaling 173,148 shares, with direct beneficial ownership of 267,814 shares remaining after both transactions.